Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. and marketed by Sunovion in the USA. In the USA since 2013, it is also approved for the treatment of depressive episodes associated with bipolar I disorder as well as bipolar II disorder in adults when used alone or in combination with lithium, valproate, or lamotrigine.
- ProName: Lurasidone
- CasNo:367514-87-2
- Molecular Formula: C28H36N4O2S
- Appearance: White or almost white crystalline powd…
- Application: Treatment of schizophrenia and bipolar…
- DeliveryTime: Prompt shipment
- PackAge: According to your requests，usually by …
- Port: China main port
- ProductionCapacity: 10 Metric Ton/Year
- Purity: 99%
- Storage: Store in a cool, dry and well-ventilat…
- Transportation: By courier or by air
- LimitNum: 10 Gram
No comments:
Post a Comment